ISRCTN98459871已完成不适用
Evaluation of I-ONE therapy in patients undergoing total knee arthoplasty: a prospective randomised controlled trial
IGEA S.p.A (Italy)0 个研究点目标入组 33 人开始时间: 2013年2月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Male and female patients aged between 60 and 85
- •2. Presenting with an advanced state of knee OA and scheduled for TKA, with varus or valgus deformity not exceeding 20° or 15°, respectively, and with a flexion contracture of less than 15°
排除标准
- •1. Previous surgery to the same knee
- •2. Omolateral hip prosthesis
- •3. Body Mass Index (BMI; kg/m2) >30
- •4. Rheumatoid arthritis
- •5. Autoimmune diseases
- •6. Systemic diseases
- •7. Cancer and the use of steroids
研究者
相似试验
招募中
不适用
Evaluation of treatment regimes in patients with cystic fibrosis and pulmonary excerbations (PEx)E84.0Cystic fibrosis with pulmonary manifestationsDRKS00012924Klinik für Pädiatrie m. S. Pneumologie und ImmunologieCampus Rudolf Virchow Klinikum100
尚未招募
不适用
Homoeopathy for VitiligoCTRI/2022/03/041296Dr Neha Singhal
尚未招募
不适用
Clinical trial of Iron supplement in anemic pregnant women.CTRI/2022/11/047376Generex Pharmassist Pvt. Ltd.
已完成
3 期
Evaluting the therapeutic and adverse effects of Interferon beta 1-a in patients with novel Coronavirus(COVID-19)IRCT20151227025726N12Shahid Beheshti University of Medical Sciences20
进行中（未招募）
不适用
A phase II study for the treatment of patients with splenic marginal lymphoma with the combination of Cyclophosfamide, Vincristine, Liposomal Doxorubicin, Predinisone and RituximabTreatment of patients with newly diagnosed splenic marginal non Hodgkin lymphomaMedDRA version: 9.1Level: LLTClassification code 10062113Term: Splenic marginal zone lymphomaEUCTR2005-000693-45-ITG.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI